DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 55 filers reported holding DOVA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $103,658,000 | +106.9% | 3,708,705 | +4.4% | 2.79% | +142.9% |
| Q2 2019 | $50,098,000 | +80.3% | 3,553,060 | +13.7% | 1.15% | +46.7% |
| Q1 2019 | $27,788,000 | +17.3% | 3,125,851 | 0.0% | 0.78% | -13.1% |
| Q4 2018 | $23,693,000 | -63.9% | 3,125,851 | 0.0% | 0.90% | -48.5% |
| Q3 2018 | $65,549,000 | -29.9% | 3,125,851 | 0.0% | 1.75% | -28.5% |
| Q2 2018 | $93,525,000 | +24.0% | 3,125,851 | +12.4% | 2.45% | +16.1% |
| Q1 2018 | $75,420,000 | +44.8% | 2,780,977 | +53.7% | 2.11% | +22.3% |
| Q4 2017 | $52,099,000 | -38.8% | 1,809,015 | -48.4% | 1.73% | +6.2% |
| Q3 2017 | $85,174,000 | +123.9% | 3,508,030 | +105.6% | 1.63% | -15.0% |
| Q2 2017 | $38,037,000 | – | 1,706,499 | – | 1.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 184,000 | $4,990,000 | 2.67% |
| NEXTHERA CAPITAL LP | 568,243 | $15,411,000 | 2.54% |
| Perceptive Advisors | 2,780,977 | $75,420,000 | 2.11% |
| Fosun International Ltd | 710,000 | $19,255,000 | 1.21% |
| EcoR1 Capital, LLC | 429,729 | $11,654,000 | 1.17% |
| Pier Capital, LLC | 217,885 | $5,909,000 | 1.01% |
| Virtus ETF Advisers LLC | 23,227 | $630,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 135,000 | $3,661,000 | 0.28% |
| Avoro Capital Advisors LLC | 125,000 | $3,390,000 | 0.16% |
| Jabre Capital Partners S.A. | 17,465 | $474,000 | 0.10% |